Research on Interventions for Cancer-Related Cognitive Impairment

A series of clinical studies has investigated non-pharmacological and pharmacological interventions for cancer-related cognitive impairment, a common side effect of chemotherapy. Recent research indicates structured exercise programs may help maintain cognitive function and reduce mental fatigue in patients, particularly those on specific treatment schedules. A separate, smaller trial suggests low-dose ibuprofen may also offer some cognitive benefits.

Phase II Trial: Exercise and Ibuprofen

A Phase II clinical trial, published in the journal CANCER, examined interventions for cancer-related cognitive impairment in patients receiving chemotherapy. The study, led by Michelle C. Janelsins, PhD, MPH, of the University of Rochester Medicine and Wilmot Cancer Institute, involved 86 patients who reported cognitive problems during chemotherapy.

Study Design:
Participants were randomized into four groups for a six-week period:

1. Exercise plus low-dose ibuprofen (200 mg twice daily).
2. Exercise plus a placebo pill.
3. Low-dose ibuprofen only.
4. Placebo only (control group).

The exercise intervention was the EXCAP (Exercise for Cancer Patients) program, a home-based regimen of progressive walking and resistance exercise.

Reported Findings:

Participants in the exercise-plus-placebo group demonstrated significantly better attention performance compared to the placebo-only group.

• The ibuprofen-only group also showed greater improvements than the placebo group.
• Both groups receiving exercise (with or without ibuprofen) exhibited improvements on a measure assessing how often others noticed the patient's cognitive difficulties.
• The ibuprofen-only group showed less improvement on a measure of short-term verbal memory compared to those not taking ibuprofen.
• The lead author stated the findings suggest possible benefits of both interventions for some cognitive domains, with a more pronounced effect observed with exercise. No adverse events were reported.

Research Context and Next Steps:

An estimated 75% to 80% of people receiving chemotherapy report cognitive issues, often described as "chemo brain," involving changes in attention, memory, and multitasking.

• Researchers noted that because exercise and ibuprofen both reduce inflammation through different pathways, their combined use could have additive effects.
• The lead author emphasized that any intervention for cognitive problems should be discussed with a healthcare provider to avoid potential harmful effects or drug interactions.
• Researchers stated that Phase III trials are needed to explore these findings further, with future studies potentially modifying the duration and dose of interventions.

Phase III Trial: Exercise During Chemotherapy

A separate, nationwide Phase III randomized controlled trial, published in JNCCN—Journal of the National Comprehensive Cancer Network, investigated the effects of the EXCAP exercise program on patients undergoing chemotherapy.

Study Design:
The trial enrolled 687 patients from 20 community oncology practices across the United States. All participants were receiving chemotherapy for the first time. Patients were randomized to receive either the EXCAP exercise prescription alongside standard chemotherapy or to receive chemotherapy alone (usual care).

The six-week EXCAP program involved personalized instructions for progressive walking (tracked with a pedometer) and resistance band exercises.

Reported Findings:

For patients on a two-week (bi-weekly) chemotherapy cycle, the EXCAP group experienced significantly less overall cognitive decline, less perceived cognitive impairment, and no increase in mental fatigue compared to the usual care group.

• Prior to chemotherapy, all patients averaged between 4,000 and 4,500 steps daily.
• During treatment, EXCAP participants maintained an average of approximately 4,351 steps per day. In contrast, the usual care group's daily steps decreased by 53%, falling below 2,000 steps per day.
• The cognitive benefits were less pronounced and not statistically significant for patients receiving chemotherapy in three- to four-week cycles.
• Greater exercise engagement was correlated with higher scores on cognitive assessments and a healthier inflammatory response pattern.
• Researchers proposed that the two-week chemotherapy cycle might allow sufficient recovery time to participate in EXCAP, which could explain the differential benefits.

Study Limitations and Recommendations:

• Study limitations included the absence of a behavioral placebo, a lack of objective cognitive assessments, and a sample predominantly composed of White females with breast cancer, which may limit the generalizability of the findings.
• Researchers recommend that cancer care providers educate patients about home-based exercise options and consider integrating structured exercise into supportive care protocols.
• The findings align with existing clinical guidelines that encourage physical activity during cancer treatment.

Meta-Analysis: Exercise and Quality of Life

A meta-analysis published in The Lancet Healthy Longevity, led by researchers at Sylvester Comprehensive Cancer Center, synthesized data from 21 randomized controlled trials involving over 3,000 women undergoing chemotherapy for breast cancer.

Reported Findings:

The analysis found that women who participated in structured exercise programs showed significant improvements in quality of life across physical, emotional, and mental health domains compared to those receiving standard care alone.

• Aerobic exercise, strength training, and combined programs all led to meaningful improvements, with no single type of exercise found to be superior.
• Researchers emphasized that exercise during treatment should be safe, personalized, and realistic, focusing on supportive movement rather than pushing through exhaustion.